Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing for 320551104 since 12/18/2024, newest first.
| Filer | % of Class | Filed | |
|---|---|---|---|
|
David S. Rosenblatt
13G/A
Amendment 7
|
10.5% |
8/14/2026
Event 6/30/2026
|
|
| David S. Rosenblatt | 10.5% | ||
| Bessemer Trust Company of Delaware, N.A., as Trustee of the 2024 Laura Thalheimer Rosenblatt Family Trust u/a/d April 1, 2024 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 2.1% | ||
|
David S. Rosenblatt
13G/A
Amendment 6
|
9.8% |
5/15/2026
Event 3/31/2026
|
|
| David S. Rosenblatt | 9.8% | ||
| Bessemer Trust Company of Delaware, N.A., as Trustee of the 2024 Laura Thalheimer Rosenblatt Family Trust u/a/d April 1, 2024 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 1.9% | ||
|
David S. Rosenblatt
13G/A
Amendment 3
|
9.3% |
2/13/2026
Event 12/31/2025
|
|
| David S. Rosenblatt | 9.3% | ||
| Bessemer Trust Company of Delaware, N.A., as Trustee of the 2024 Laura Thalheimer Rosenblatt Family Trust u/a/d April 1, 2024 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 1.8% | ||
|
Philotimo Fund, LP
13G
|
5.3% |
2/6/2026
Event 2/2/2026
|
|
| Philotimo Fund, LP | 3.3% | ||
| Kanen Wealth Management LLC | 5.3% | ||
| Philotimo Focused Growth & Income Fund | 2.0% | ||
| Kanen David | 5.3% | ||
|
Sofina Capital S.A.
13G
|
0% |
1/15/2026
Event 11/14/2025
|
|
| Sofina Capital S.A. | 0% | ||
| Sofina SA | 0% | ||
|
John A. Catsimatidis Jr.
13D
|
5.1% |
11/21/2025
Event 11/14/2025
|
|
| John A. Catsimatidis Jr. | 5.1% | ||
| Red Apple Group, Inc. | 5.1% | ||
| United Acquisition Corp. | 5.1% | ||
| United Refining, Inc. | 5.1% | ||
| John A. Catsimatidis | 5.1% | ||
|
David S. Rosenblatt
13G/A
Amendment 4
|
10.4% |
11/14/2025
Event 9/30/2025
|
|
| David S. Rosenblatt | 10.4% | ||
| Bessemer Trust Company of Delaware, N.A., as Trustee of the 2024 Laura Thalheimer Rosenblatt Family Trust u/a/d April 1, 2024 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 1.8% | ||
|
David S. Rosenblatt
13G/A
Amendment 3
|
10.2% |
8/14/2025
Event 6/30/2025
|
|
| David S. Rosenblatt | 10.2% | ||
| Bessemer Trust Company of Delaware, N.A., as Trustee of the 2024 Laura Thalheimer Rosenblatt Family Trust u/a/d April 1, 2024 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 1.8% | ||
|
Benchmark Capital Partners V L P
13G/A
Amendment 3
|
20.0% |
2/14/2025
Event 12/31/2024
|
|
| Benchmark Capital Partners V, L.P. | 7.7% | ||
| Benchmark Founders' Fund V, L.P. | 0.9% | ||
| Benchmark Founders' Fund V-A, L.P. | 0.2% | ||
| Benchmark Founders' Fund V-B, L.P. | 0.1% | ||
| Benchmark Capital Management Co. V, L.L.C. | 10.0% | ||
| Benchmark Capital Partners VII, L.P. | 8.0% | ||
| Benchmark Founders' Fund VII, L.P. | 0.9% | ||
| Benchmark Founders' Fund VII-B, L.P. | 1.2% | ||
| Benchmark Capital Management Co. VII, L.L.C. | 10.0% | ||
| Alexandre Balkanski | 10.0% | ||
| Matthew R. Cohler | 10.2% | ||
| Bruce W. Dunlevie | 20.0% | ||
| Peter Fenton | 20.0% | ||
| J. William Gurley | 20.0% | ||
| Kevin R. Harvey | 20.0% | ||
| Robert C. Kagle | 10.0% | ||
| Mitchell H. Lasky | 20.0% | ||
|
David S. Rosenblatt
13G/A
Amendment 2
|
9.1% |
11/14/2024
Event 9/30/2024
|
|
| David S. Rosenblatt | 9.1% | ||
| 2012 Laura T. Rosenblatt Family Trust dated December 4, 2012 | 0.1% | ||
| 2012 David Rosenblatt Family Trust dated November 30, 2012 | 1.8% | ||
| Beck Mack & Oliver LLC 13G | 8.3% |
11/7/2024
Event 11/1/2024
|
| Period | Filings | Shares, Excl. Options | Value, Excl. Options |
|---|---|---|---|
| 2026 Q3 | 1 | 312 | $1.25 k |
| 2026 Q2 | 88 | 13.1 M | $64.4 M |
| 2026 Q1 | 86 | 14.4 M | $79.1 M |
| 2025 Q4 | 89 | 15.3 M | $91.4 M |
| 2025 Q3 | 70 | 13.5 M | $35.1 M |
| 2025 Q2 | 78 | 13.6 M | $37.3 M |
| 2025 Q1 | 80 | 14.7 M | $44.6 M |
| 2024 Q4 | 77 | 14.6 M | $51.8 M |
| 2024 Q3 | 81 | 16.3 M | $71.8 M |
| 2024 Q2 | 81 | 15.8 M | $70.8 M |
| 2024 Q1 | 84 | 18.8 M | $112 M |
| 2023 Q4 | 82 | 19.4 M | $90.8 M |
| 2023 Q3 | 73 | 19.2 M | $69.8 M |
| 2023 Q2 | 77 | 19.8 M | $74.1 M |
| 2023 Q1 | 85 | 21.2 M | $84.2 M |
| 2022 Q4 | 96 | 21.3 M | $108 M |
| 2022 Q3 | 89 | 20.6 M | $129 M |
| 2022 Q2 | 69 | 19.7 M | $112 M |
| 2022 Q1 | 67 | 19.5 M | $156 M |
| 2021 Q4 | 69 | 19.4 M | $243 M |
| 2021 Q3 | 53 | 17.6 M | $216 M |
| 2021 Q2 | 63 | 17.1 M | $589 M |